Page last updated: 2024-10-26

etidronate and Apoplexy

etidronate has been researched along with Apoplexy in 7 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research Excerpts

ExcerptRelevanceReference
"Before the drugs were started, patients later initiating alendronate or raloxifene had fewer strokes than the controls."3.77Stroke in relation to use of raloxifene and other drugs against osteoporosis. ( Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P, 2011)
"After patients with osteoporosis are identified, the challenge is to treat them appropriately."2.47Treatments for osteoporosis in people with a disability. ( Smith, EM, 2011)
"Neurological diseases, including Alzheimer's disease, stroke, and Parkinson's disease have been reported to increase the risk for fractures."2.44Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. ( Iwamoto, J; Matsumoto, H; Takeda, T, 2008)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, Y3
Iwamoto, J3
Honda, Y1
Vestergaard, P1
Schwartz, K1
Pinholt, EM1
Rejnmark, L1
Mosekilde, L1
Smith, EM1
Kanoko, T1
Satoh, K1
Poole, KE1
Warburton, EA1
Reeve, J1
Matsumoto, H1
Takeda, T1
Asoh, T1
Kaji, M1
Oizumi, K1

Reviews

2 reviews available for etidronate and Apoplexy

ArticleYear
Treatments for osteoporosis in people with a disability.
    PM & R : the journal of injury, function, and rehabilitation, 2011, Volume: 3, Issue:2

    Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Disabled Persons; Etidronic Acid; Hu

2011
Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.
    Current medical research and opinion, 2008, Volume: 24, Issue:5

    Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Bone Density Conservation Agents; Conf

2008

Trials

3 trials available for etidronate and Apoplexy

ArticleYear
RETRACTED: Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2010, Volume: 19, Issue:3

    Topics: Aged; Body Mass Index; Bone Density; Bone Density Conservation Agents; Calcium; Chronic Disease; Dis

2010
Risedronate therapy for prevention of hip fracture after stroke in elderly women.
    Neurology, 2005, Mar-08, Volume: 64, Issue:5

    Topics: Accidental Falls; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Double-Blind Method

2005
Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2000, Volume: 15, Issue:12

    Topics: Absorptiometry, Photon; Aged; Amino Acids; Bone Density; Bone Diseases, Metabolic; Calcium; Collagen

2000

Other Studies

2 other studies available for etidronate and Apoplexy

ArticleYear
Stroke in relation to use of raloxifene and other drugs against osteoporosis.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2011, Volume: 22, Issue:4

    Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Case-Control Studies; Denmar

2011
Risedronate therapy for prevention of hip fracture after stroke in elderly women.
    Neurology, 2005, Nov-08, Volume: 65, Issue:9

    Topics: Accidental Falls; Aged; Bone Density Conservation Agents; Causality; Clinical Trials as Topic; Etidr

2005